Probiotics were used as an adjuvant therapy for rheumatoid arthritis in nine studies comprising 361 patients. The results showed a substantial reduction in IL-6, but an unclear clinical outcome. For clarity, additional high-quality trials are required. This evidence concerns the gene IL6 and rheumatoid arthritis.